Yaz MDL Approved

The Judicial Panel on MultiDistrict Litigation (JPML) yesterday approved MDL-2100, In Re: Yasmin and YAZ (Drospirenone) Marketing, Sales Practices and Products Liability Litigation. John Cord’s Drug Recall Lawyer Blog provides all of the details. You can find an explanation of what the Yaz MDL means to pending and future Yaz lawsuits here.